These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 10858407
1. Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients. Frey B, Pacher R, Locker G, Bojic A, Hartter E, Woloszczuk W, Stanek B. Chest; 2000 Jun; 117(6):1713-9. PubMed ID: 10858407 [Abstract] [Full Text] [Related]
6. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. Pacher R, Stanek B, Hülsmann M, Koller-Strametz J, Berger R, Schuller M, Hartter E, Ogris E, Frey B, Heinz G, Maurer G. J Am Coll Cardiol; 1996 Mar 01; 27(3):633-41. PubMed ID: 8606275 [Abstract] [Full Text] [Related]
10. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure. Hülsmann M, Stanek B, Frey B, Berger R, Rödler S, Siegel A, Hartter E, Schuller M, Ogris E, Pacher R. J Heart Lung Transplant; 1997 May 01; 16(5):556-62. PubMed ID: 9171275 [Abstract] [Full Text] [Related]
11. Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure. Nanas JN, Kontoyannis DA, Alexopoulos GP, Anastasiou-Nana MI, Tsagalou EP, Stamatelopoulos SF, Moulopoulos SD. Chest; 2001 Apr 01; 119(4):1173-8. PubMed ID: 11296186 [Abstract] [Full Text] [Related]
15. Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome. Capomolla S, Febo O, Opasich C, Guazzotti G, Caporotondi A, La Rovere MT, Gnemmi M, Mortara A, Vona M, Pinna GD, Maestri R, Cobelli F. Eur J Heart Fail; 2001 Oct 01; 3(5):601-10. PubMed ID: 11595609 [Abstract] [Full Text] [Related]
16. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure]. Wutte M, Hülsmann M, Berger R, Rödler S, Frey B, Stanek B, Pacher R. Wien Klin Wochenschr; 1998 Jul 31; 110(13-14):473-8. PubMed ID: 9746960 [Abstract] [Full Text] [Related]
17. Dose-effect relationships of prostaglandin E1 in severe endstage chronic heart failure. Stanek B, Pacher R. Jpn Heart J; 1997 Jan 31; 38(1):53-65. PubMed ID: 9186281 [Abstract] [Full Text] [Related]
19. Hemodynamic effect of oral TA-064 after dobutamine in congestive heart failure. Takatsu Y, Yui Y, Hattori R, Sakaguchi K, Susawa T, Yui N, Kawai C. Jpn Circ J; 1987 Jun 31; 51(6):611-6. PubMed ID: 3312701 [Abstract] [Full Text] [Related]